Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL286882 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL2446607 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL362235 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL1866839 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL7759526 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL635580 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL8775234 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL164301 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL2979400 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL1963378 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713317-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | Adama Agan Ltd. (IL) | 2026-03-25 | — | — | EP | claimed |
| WO-2024236570-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | ADAMA AGAN LTD. (IL) | 2024-11-21 | — | — | WO | claimed |
| CN-116376340-B | Water-resistant intumescent phosphorus-nitrogen flame retardant and application thereof in coating | 广东百安环保新材料有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-116948547-A | Novel white reinforced photovoltaic backboard base film, preparation method and application thereof | 宁波勤邦新材料科技股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| EP-3435766-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | Dentsply Sirona Inc. (US) | 2019-02-06 | — | — | EP | claimed |
| US-20170280725-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | DENTSPLY SIRONA INC (US) | 2017-10-05 | — | — | US | claimed |
| WO-2017173294-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | DENTSPLY SIRONA INC. (US) | 2017-10-05 | — | — | WO | claimed |
| CN-106867109-A | A kind of low VOC PP composite materials and preparation method thereof | 常州塑金高分子科技有限公司 | 2017-06-20 | — | — | CN | claimed |
| EP-2152845-B1 | HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES | SOLVAY USA INC (US) | 2017-03-29 | — | — | EP | claimed |
| CN-105999358-A | Method for preparing slow-release antibacterial dressing | 广东泰宝医疗科技股份有限公司 | 2016-10-12 | — | — | CN | claimed |
| US-20020090349-A1 | Process for the biocidal treatment of surface | BERGERON VANCE (FR) | 2002-07-11 | — | — | US | claimed |
| US-6316575-B1 | MELT TRANSESTERIFICATION OF DIOL COMPOUND AND CARBOANTE COMPOUND USING CATALYST COMPRISING A PHOSPHORUS-CONTAINING BASIC COMPOUND QUATERNARY PHOSPHONIUM SALT TO FORM POLYCARBONATE | IDEMITSU KOSAN CO., LTD. (JP) | 2001-11-13 | — | — | US | claimed |
| EP-1094706-A1 | PROCESS FOR THE BIOCIDAL TREATMENT OF SURFACES | RHODIA CHIMIE (FR) | 2001-05-02 | — | — | EP | claimed |
| WO-2000002449-A1 | PROCESS FOR THE BIOCIDAL TREATMENT OF SURFACES | RHODIA CHIMIE (FR) | 2000-01-20 | — | — | WO | claimed |
| WO-1998047359-A1 | RAPID AND LONG LASTING BIOCIDAL SYSTEM | RHODIA LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| EP-0724562-B1 | SYNTHESIS OF SPHINGOSINES | VIRGINIA TECH INTELL PROP (US) | 1998-06-03 | — | — | EP | claimed |
| EP-0724562-A1 | SYNTHESIS OF SPHINGOSINES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1996-08-07 | — | — | EP | claimed |
| US-5488167-A | Synthesis of sphingosines | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1996-01-30 | — | — | US | claimed |
| WO-1995011222-A1 | SYNTHESIS OF SPHINGOSINES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1995-04-27 | — | — | WO | claimed |
| EP-0213547-B1 | CYCLOHEXANEALKANOIC ACIDS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-12-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170280725-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | FGB, TFPI, F12 | HIF1A 797/4885TRAP1 3581/4885CHRNA7 4851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.